FILTER
FILTERED INTERVIEW RESULTS
Darrell White
EXECUTIVE GENERAL MANAGER AMERICAS, THIESS
Thiess is upbeat on adding more services and expanding its operations in Chile.
Marco Riveros
VICE PRESIDENT, CHILEAN COPPER COMMISSION (COCHILCO)
The Chilean Copper Commission (Cochilco) speaks to GBR about how it assisted Chile’s copper industry through a difficult period.
Mario Theurl & Dirk Pförtner
TECHNICAL MANAGER, STRABAG ZÜBLIN & COMMERCIAL MANAGER, STRABAG ZÜBLIN CHILE
Züblin is a major player in the development and preparation of underground mines in Chile, providing services from construction to mining.
Dave Lawson
PRESIDENT MINING AND MINERALS, WOOD
Wood explains how it provides mining solutions that utilize applied intelligence to enhance operational and environmental sustainability for Chilean mines.
Tomás Fischer Ballerini
GENERAL MANAGER, EDYCE
Edyce is confident that the economic outlook for the rest of 2021 and 2022 is promising, an that the project development pipeline of different mining companies in Chile will be executed as planned.
Rodrigo Prado
GENERAL MANAGER, TECNO FAST
Tecno Fast explains how it can help mining companies in Chile with infrastructure services including camps and modular buildings.
Carlos Escudero
GENERAL MANAGER, GEOCOM
GEOCOM is a leading provider of geospatial equipment and software used in measurements for mining in Chile.
Pedro Damjanic
SENIOR VP - MINING, FINNING
Finning explains how, together with CAT, it is prepared to help Chiles mines move towards autonomy.
Michael Kosowan
PRESIDENT AND CEO, TORQ RESOURCES
Torq Resources speaks with GBR about it’s exploration projects in Chile.
Marcelo Celis
GENERAL MANAGER, BOSCH REXROTH CHILE
"I see a clear growth potential for our company in Chile through product expansion over our existing customer base."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
